Pharmacology Update: Emergency and Controller Medications for Treatment of Asthma

Abstract

Asthma is the most common noncommunicable chronic childhood disease, affecting more than 5 million children in the United States. Asthma is the leading cause of school absenteeism. Treatments for asthma are divided into fast-acting medications that are used to relieve symptoms and slower acting (controller) medications that prevent symptoms. Albuterol is the most common fast acting medication for asthma, and it exists in multiple forms, including metered-dose inhaler and nebulized therapy. The use of spacers and holding chambers can further improve medication deposition in the airway. The cornerstone controller therapy for asthma is inhaled corticosteroid. Other medications for asthma include long-acting beta agonists, long-acting antimuscarinics, and antileukotrienes. The newest agents for controller asthma therapies are biologics.

Keywords

asthma albuterol controller medications emergency medications inhaler nebulizer wheeze

Get full access to this article

View all access options for this article.

References

American Academy of Asthma Allergy and Immunology & University of Wisconsin–Madison, Department of Medicine. (2016). SAMPRO™ toolkit. https://hipxchange.org/SAMPRO

Benton

Thomas

R. C.

Nickerson

B. G.

McQuitty

J. C.

Okikawa

(1989). Experience with a metered-dose inhaler with a spacer in the pediatric emergency department. American Journal of Diseases of Children, 143(6), 678-681. https://doi.org/10.1001/archpedi.1989.02150180056020

Centers for Disease Control and Prevention. (2019). Most recent national asthma data. https://www.cdc.gov/asthma/most_recent_national_asthma_data.htm

Centers for Disease Control and Prevention. (2020). Common asthma triggers. https://www.cdc.gov/asthma/triggers.html#:~:text=Sinus%20infections%2C%20allergies%2C%20pollen%2C,also%20trigger%20an%20asthma%20attack

Cloutier

M. M.

Baptist

A. P.

Blake

K. V.

Brooks

E. G.

Bryant-Stephens

DiMango

Dixon

A. E.

Elward

K. S.

Hartert

Krishnan

J. A.

Lemanske

R. F.

Ouellette

D. R.

Pace

W. D.

Schatz

Skolnik

N. S.

Stout

J. W.

Teach

S. J.

Umscheid

C. A.

Walsh

C. G.

(2020). 2020 Focused updates to the asthma management guidelines: A report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group. Journal of Allergy and Clinical Immunology, 146(6), 1217-1270. https://doi.org/10.1016/j.jaci.2020.10.003

Conrad

L. A.

Cabana

M. D.

Rastogi

(2020). Defining pediatric asthma: phenotypes to endotypes and beyond. Pediatric Research. Advance online publication. https://doi.org/10.1038/s41390-020-01231-6

Cunha

J. P.

(2021). Albuterol. https://www.rxlist.com/consumer_albuterol_ventolin_hfa/drugs-condition.htm

Cydulka

Davison

Grammer

Parker

Mathews

J. T.

(1988). The use of epinephrine in the treatment of older adult asthmatics. Annals of Emergency Medicine, 17(4), 322-326. https://doi.org/10.1016/s0196-0644(88)80772-8

Gardenhire

D. S.

Burnett

Strickland

Myers

T. R.

(2017). A guide to aerosol delivery devices for respiratory therapists (4th ed.). https://www.aarc.org/wp-content/uploads/2015/04/aerosol_guide_rt.pdf

10.

Hasegawa

Craig

S. S.

Teach

S. J.

Camargo

J. C. A.

(2021). Management of asthma exacerbations in the emergency department. Journal of Allergy and Clinical Immunology in Practice, 9(7), 2599-2610. https://doi.org/10.1016/j.jaip.2020.12.037

11.

Rachelefsky

G. S.

Katz

R. M.

Siegel

S. C.

(1982). Oral albuterol in the treatment of childhood asthma. Pediatrics, 69(4), 397-403. https://doi.org/10.2165/00003495-198938010-00004.

12.

Reddel

H. K.

FitzGerald

J. M.

Bateman

E. D.

Bacharier

L. B.

Becker

Brusselle

Buhl

Cruz

A. A.

Fleming

Inoue

Wai-San Ko

Krishnan

J. A.

Levy

M. L.

Lin

Pedersen

S. E.

Sheikh

Yorgancioglu

Boulet

L.-P.

(2019). GINA 2019: A fundamental change in asthma management: Treatment of asthma with short-acting bronchodilators alone is no longer recommended for adults and adolescents. European Respiratory Journal, 53(6), Article 1901046. https://doi.org/10.1183/13993003.01046-2019

13.

Williams

D. M.

Rubin

B. K.

(2018). Clinical pharmacology of bronchodilator medications. Respiratory Care, 63(6), 641-654. https://doi.org/10.4187/respcare.06051

14.

Zainudin

B. M.

Biddiscombe

Tolfree

S. E.

Short

Spiro

S. G.

(1990, Jun). Comparison of bronchodilator responses and deposition patterns of salbutamol inhaled from a pressurised metered dose inhaler, as a dry powder, and as a nebulised solution. Thorax, 45(6), 469-473. https://doi.org/10.1136/thx.45.6.469